(Q43920822)

28 November 2017

title

Cytomegalovirus pneumonia prior to engraftment following T-cell depleted bone marrow transplantation (English)

1 reference

Cytomegalovirus pneumonia

28 November 2017

main subject

1 reference

A Nagler

1

1 reference

28 November 2017

H Elishoov

2

1 reference

28 November 2017

Y Kapelushnik

3

1 reference

28 November 2017

R Breuer

4

1 reference

28 November 2017

R Or

5

1 reference

28 November 2017

D Engelhard

6

1 reference

28 November 2017

publication date

1 January 1994

1 reference

28 November 2017

1 reference

28 November 2017

volume

11

1 reference

28 November 2017

issue

3-4

1 reference

28 November 2017

page(s)

127-132

1 reference

Treatment of Interstitial Pneumonitis Due to Cytomegalovirus with Ganciclovir and Intravenous Immune Globulin: Experience of European Bone Marrow Transplant Group

28 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02999860

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02999860

Severe herpesvirus infections in an adolescent without natural killer cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02999860

Risk factors for cytomegalovirus infection after human marrow transplantation

21 January 2018

1 reference

12 December 2020

Incidence and prognosis of cytomegalovirus infections following allogenic bone marrow transplantation

1 reference

12 December 2020

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation

1 reference

12 December 2020

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

1 reference

12 December 2020

Cytomegalovirus infection and disease after T cell depleted allogeneic bone marrow transplantation for malignant hematologic diseases

1 reference

12 December 2020

Infections in bone marrow transplant recipients

1 reference

12 December 2020

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

12 December 2020

Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT.

1 reference

12 December 2020

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

12 December 2020

Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infection

1 reference

12 December 2020

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

12 December 2020

Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin

1 reference

12 December 2020

Early and late interstitial pneumonia following human bone marrow transplantation

1 reference

12 December 2020

Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.

1 reference

12 December 2020

Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts

1 reference

12 December 2020

DHPG at CMV viremia after allogeneic bone marrow transplantation. Result over a four year period (1986-1990)

1 reference

12 December 2020

Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society

1 reference

12 December 2020

Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).

1 reference

12 December 2020

Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs

1 reference

12 December 2020

Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02999860

1 reference

Dimensions Publication ID

28 November 2017

1001349032

0 references

1 reference